Dr. Mehrdad M. Tavallaee, MD

Dr. Tavallaee practices at Mercy Health - Lorain Hospital in Lorain, Ohio, part of Bon Secours Mercy Health.

Dr. Tavallaee's NPI, 1689625634, was assigned on May 15, 2006. Dr. Tavallaee holds Ohio license 35079062T.

Dr. Tavallaee's primary practice is Mercy Health - Lorain Hospital, at 3700 Kolbe Road, Lorain, OH 44053 in Lorain County. The practice phone is (440) 960-4000.

Dr. Tavallaee's primary practice is Mercy Health - Lorain Hospital in Lorain, Ohio, part of Bon Secours Mercy Health. Dr. Tavallaee is also affiliated with University Hospitals Cleveland Medical Center. The medical group on file is University Eyecare. Dmand AI also links Dr. Tavallaee to 2 more hospitals, 4 hospices, 3 skilled nursing facilities, 2 group practices and clinics, 2 home health agencies and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tavallaee practices, 15 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Tavallaee's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Tavallaee is licensed in Ohio.

CMS data shows 3,499 Medicare services from Dr. Tavallaee across 27 procedure codes in 2024, for 603 Medicare patients. Medicare paid $198,002 for them.

CMS counts 603 Medicare patients who saw Dr. Tavallaee in 2024. The largest group is 75 to 84, with 195 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tavallaee's median patient age at 74, with 56% women.

In 2024, Dr. Tavallaee wrote 38,778 Medicare Part D claims for 1,043 patients. 87% of them were for generic drugs. CMS names the drug for 37,651 of them, across 280 drugs with 11 or more claims each, at $2,456,095 in total drug cost. In 2023, CMS named 35,780 claims across 288 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Tavallaee for performance year 2024, reported through an alternative payment model (APM). Dr. Tavallaee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tavallaee as offering telehealth. CMS counts 39 procedures of colonoscopy by Dr. Tavallaee, more than 58% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 619 general payments to Dr. Tavallaee from 58 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Janssen Pharmaceuticals, Inc paid the most, $797.